Pfizer and BioNTech say data shows COVID vaccine is more than 70% effective in young children, with cases rising in just 7 states
Pfizer and its German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in children 6 months to 4 years old. Businesses EFP, -1.88% BTX, -0.03% said updated analysis of 34 cases occurring at least seven days after a three-dose regimen showed a vaccine efficacy of 73.2% in children in this age group. … Read more